These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9848452)

  • 1. In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
    Coudron PE; Stratton CW
    J Antimicrob Chemother; 1998 Nov; 42(5):657-60. PubMed ID: 9848452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
    Graham DY; Saeed MA; Hoffman J; El-Zimaity HM; Kwon DH; Osato MS
    Aliment Pharmacol Ther; 2001 Apr; 15(4):513-8. PubMed ID: 11284780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
    Ling TK; Cheng AF; Sung JJ; Yiu PY; Chung SS
    Helicobacter; 1996 Mar; 1(1):57-61. PubMed ID: 9398914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
    González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
    Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
    Debets-Ossenkopp YJ; Herscheid AJ; Pot RG; Kuipers EJ; Kusters JG; Vandenbroucke-Grauls CM
    J Antimicrob Chemother; 1999 Apr; 43(4):511-5. PubMed ID: 10350380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
    Liang X; Xu X; Zheng Q; Zhang W; Sun Q; Liu W; Xiao S; Lu H
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):802-7.e1. PubMed ID: 23376004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
    Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
    J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
    Boyanova L; Stancheva I; Spassova Z; Katzarov N; Mitov I; Koumanova R
    J Med Microbiol; 2000 May; 49(5):415-418. PubMed ID: 10798553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.
    Chiba N
    Can J Gastroenterol; 2000 Nov; 14(10):885-9. PubMed ID: 11111112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
    Yan WH; Chen J; Hu HJ; Yu JD; Huang XL; Li ZY
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):708-11. PubMed ID: 18021568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
    Ogata SK; Godoy AP; da Silva Patricio FR; Kawakami E
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):645-8. PubMed ID: 23403439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.
    Kim JJ; Reddy R; Lee M; Kim JG; El-Zaatari FA; Osato MS; Graham DY; Kwon DH
    J Antimicrob Chemother; 2001 Apr; 47(4):459-61. PubMed ID: 11266421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB
    Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
    [No Abstract]   [Full Text] [Related]  

  • 16. Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
    Dekhnich N; Ivanchik N; Kozlov R; Alimov A; Steshits A; Kirsov P; Pandav K
    Helicobacter; 2018 Dec; 23(6):e12545. PubMed ID: 30324756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
    Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
    BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance.
    Kwon DH; Lee M; Kim JJ; Kim JG; El-Zaatari FA; Osato MS; Graham DY
    Antimicrob Agents Chemother; 2001 Jan; 45(1):306-8. PubMed ID: 11120984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori.
    Coudron PE; Stratton CW
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2641-4. PubMed ID: 8592994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.
    Jenks PJ; Ferrero RL; Tankovic J; Thiberge JM; Labigne A
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2623-9. PubMed ID: 10991835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.